Does LEUPROLIDE Cause Hospitalisation? 355 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 355 reports of Hospitalisation have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.5% of all adverse event reports for LEUPROLIDE.
355
Reports of Hospitalisation with LEUPROLIDE
0.5%
of all LEUPROLIDE reports
102
Deaths
345
Hospitalizations
How Dangerous Is Hospitalisation From LEUPROLIDE?
Of the 355 reports, 102 (28.7%) resulted in death, 345 (97.2%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 355 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which LEUPROLIDE Alternatives Have Lower Hospitalisation Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM